Shares of Regeneron are ripping higher in pre-market trading this morning, building on its gains from Wednesday evening, after the company submitted its antibody cocktail to the FDA for emergency-use approval.
Originally tweeted by Donald J. Trump (@realDonaldTrump) on October 7, 2020.